Euro RSCG Life to handle all new diabetes, thrombosis comms for Sanofi-Aventis

Sanofi-Aventis appointed Euro RSCG Life to handle all communications programs for all new diabetes and thrombosis drugs while renewing the network’s global assignments on Lovenox/Clexane, Lantus and Apidra, which the Havas network has handled since 2004. The firm also named Euro RSCG C&O to handle corporate communications.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions